Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-3930

ABSTRACT: Expression profiling of DT40 cells treated with Hydroxyurea compared with DT40 mutated for FANCJ or for WRN and BLM

PROVIDER: E-MTAB-3930 | ExpressionAtlas | 2015-09-29

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MTAB-3930-analysis-methods.tsv	Tabular
	E-MTAB-3930-atlasExperimentSummary.Rdata	Rdata
	E-MTAB-3930-configuration.xml	Xml
	E-MTAB-3930-percentile-ranks.tsv	Tabular
	E-MTAB-3930.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 75

Similar Datasets

2HG concentration in human IDH1m cells

Project description:SJGBM2 and MGG8 glioma cells were stable transfected with IDH1-R132H mutated. The expression of IDH1-R132H was confirmed by Western Blot assay. The aim of this project is analyze the production of 2HG in the stable transfected cells (SJGBM-IDH1m and MGG8-IDH1m) compared with the control group WT.

2017-07-14 | ST000824 | MetabolomicsWorkbench

Homo sapiens

Project description:Transcriptional profiling of 293T cells treated with 2µM camptothecin compared to untreated cells

| PRJNA92663 | ENA

Mus musculus

Project description:Expression data from J147-treated HT22 cells compared to untreated HT22 cells

| PRJNA194544 | ENA

Proteomic of anlotinib in TP53-mutated non-small cell lung cancer

Project description:Our study provides a profile of proteins and their related pathways in anlotinib-treated TP53-mutated NSCLC cells (H1299).

2024-09-25 | PXD056214 |

miRNA expression analysis of E2F1 knockdown cells compared to control siRNA treated cells

Project description:miRNA expression analysis of E2F1 knockdown cells compared to control siRNA treated cells

| PRJNA614009 | ENA

Alteration of treatment of the ALK inhibitor in ALK-amplified neuroblastoma

Project description:Anaplastic Lymphoma Kinase (ALK) most frequently mutated in neuroblastoma (NB) and is atractive molecular target for therapy. However, efficacy of the ALK inhibitor against ALK-amplified NB is unclear. To elucidate genetic alterations induced by treatment of the ALK inhibitor, we compared expression profile between ALK inhibitor-treated and DMSO-treated NB39nu cells using Agilent SurePrint G3 Human GE 8x60K V2 Microarray Kit

2017-11-28 | GSE107354 | GEO

Homo sapiens

Project description:Gene expression signatures for entecavir treated HepG2.2.15 cells compared to entecavir untreated HepG2.2.15 cells

| PRJNA322658 | ENA

Mus musculus

Project description:Expression data for MCMV-treated compared to Mock-treated Mut3 neurospheres

| PRJNA147737 | ENA

MiRNA expression profiling in pancreatic cancer cells compared to normal epihelial cells

Project description:MiRNA expression profiling in pancreatic cancer cells compared to normal epihelial cells

| PRJNA1047559 | ENA

Homo sapiens

Project description:Expression profiling of ATRA treated NB4 cells